BACKGROUND: Patients with lung cancer often experience a reduction in exercise tolerance, muscle weakness and decreased quality of life. Although the effectiveness of pulmonary rehabilitation programs is well recognized in other forms of cancers and in many pulmonary diseases, few researchers have studied its impact in patients with lung cancer, particularly in those awaiting lung resection surgery (LRS). OBJECTIVES: To investigate the feasibility of a short, home-based exercise training program (HBETP) with patients under investigation for non-small cell lung cancer and potential candidates for LRS, and to determine the effectiveness of this program on exercise tolerance, skeletal muscle strength and quality of life. METHODS: Sixteen patients with lung cancer awaiting LRS participated in a four-week HBETP including moderate aerobic activities (walking and cycling) and muscle training performed three times weekly. Before and after the intervention, a cardiopulmonary exercise test, a 6 min walk test and the assessment of muscle strength and quality of life were performed. RESULTS: Thirteen patients completed the four-week HBETP and all the patients completed >75% of the prescribed exercise sessions. The duration of the cycle endurance test (264±79 s versus 421±241 s; P<0.05) and the 6 min walk test distance (540±98 m versus 568±101 m; P<0.05) were significantly improved. Moreover, the strength of the deltoid, triceps and hamstrings were significantly improved (∆ post-pre training 1.82±2.83 kg, 1.32±1.75 kg and 3.41±3.7 kg; P<0.05, respectively). CONCLUSION: In patients with lung cancer awaiting LRS, HBETP was feasible and improved exercise tolerance and muscle strength. This may be clinically relevant because poor exercise capacity and muscle weakness are predictors of postoperative complications.
BACKGROUND:Patients with lung cancer often experience a reduction in exercise tolerance, muscle weakness and decreased quality of life. Although the effectiveness of pulmonary rehabilitation programs is well recognized in other forms of cancers and in many pulmonary diseases, few researchers have studied its impact in patients with lung cancer, particularly in those awaiting lung resection surgery (LRS). OBJECTIVES: To investigate the feasibility of a short, home-based exercise training program (HBETP) with patients under investigation for non-small cell lung cancer and potential candidates for LRS, and to determine the effectiveness of this program on exercise tolerance, skeletal muscle strength and quality of life. METHODS: Sixteen patients with lung cancer awaiting LRS participated in a four-week HBETP including moderate aerobic activities (walking and cycling) and muscle training performed three times weekly. Before and after the intervention, a cardiopulmonary exercise test, a 6 min walk test and the assessment of muscle strength and quality of life were performed. RESULTS: Thirteen patients completed the four-week HBETP and all the patients completed >75% of the prescribed exercise sessions. The duration of the cycle endurance test (264±79 s versus 421±241 s; P<0.05) and the 6 min walk test distance (540±98 m versus 568±101 m; P<0.05) were significantly improved. Moreover, the strength of the deltoid, triceps and hamstrings were significantly improved (∆ post-pre training 1.82±2.83 kg, 1.32±1.75 kg and 3.41±3.7 kg; P<0.05, respectively). CONCLUSION: In patients with lung cancer awaiting LRS, HBETP was feasible and improved exercise tolerance and muscle strength. This may be clinically relevant because poor exercise capacity and muscle weakness are predictors of postoperative complications.
Authors: Ahmedin Jemal; Freddie Bray; Melissa M Center; Jacques Ferlay; Elizabeth Ward; David Forman Journal: CA Cancer J Clin Date: 2011-02-04 Impact factor: 508.702
Authors: M A Puhan; D Chandra; Z Mosenifar; A Ries; B Make; N N Hansel; R A Wise; F Sciurba Journal: Eur Respir J Date: 2010-08-06 Impact factor: 16.671
Authors: Lee W Jones; Neil D Eves; Bercedis L Peterson; Jennifer Garst; Jeffrey Crawford; Miranda J West; Stephanie Mabe; David Harpole; William E Kraus; Pamela S Douglas Journal: Cancer Date: 2008-12-15 Impact factor: 6.860
Authors: Jennifer S Temel; Joseph A Greer; Sarah Goldberg; Paula Downes Vogel; Michael Sullivan; William F Pirl; Thomas J Lynch; David C Christiani; Matthew R Smith Journal: J Thorac Oncol Date: 2009-05 Impact factor: 15.609
Authors: G Stephen Morris; Gail H Gallagher; Mary F Baxter; Kevin E Brueilly; Janet S Scheetz; Maaheen M Ahmed; Vickie R Shannon Journal: Arch Phys Med Rehabil Date: 2009-05 Impact factor: 3.966
Authors: William F Pirl; Jennifer S Temel; Andrew Billings; Constance Dahlin; Vicki Jackson; Holly G Prigerson; Joseph Greer; Thomas J Lynch Journal: Psychosomatics Date: 2008 May-Jun Impact factor: 2.386
Authors: Carolyn J Peddle; Lee W Jones; Neil D Eves; Tony Reiman; Christopher M Sellar; Timothy Winton; Kerry S Courneya Journal: Cancer Nurs Date: 2009 Mar-Apr Impact factor: 2.592
Authors: Pat G Camp; Paul Hernandez; Jean Bourbeau; Ashley Kirkham; Richard Debigare; Michael K Stickland; Donna Goodridge; Darcy D Marciniuk; Jeremy D Road; Mohit Bhutani; Gail Dechman Journal: Can Respir J Date: 2015-04-07 Impact factor: 2.409
Authors: D Pfirrmann; P Simon; M Mehdorn; M Hänsig; S Stehr; L Selig; A Weimann; M Knödler; F Lordick; A Mehnert; I Gockel Journal: Chirurg Date: 2018-11 Impact factor: 0.955
Authors: David J Finley; Courtney J Stevens; Jennifer A Emond; John A Batsis; Kayla A Fay; Christian Darabos; Olivia A Sacks; Summer B Cook; Kathleen Doyle Lyons Journal: Surg Oncol Date: 2021-03-05 Impact factor: 2.388
Authors: Maja S Sommer; Karen Trier; Jette Vibe-Petersen; Malene Missel; Merete Christensen; Klaus R Larsen; Seppo W Langer; Carsten Hendriksen; Paul Frost Clementsen; Jesper H Pedersen; Henning Langberg Journal: Integr Cancer Ther Date: 2016-05-04 Impact factor: 3.279
Authors: Paul C LaStayo; Thomas K Varghese; Cornelia M Ulrich; Caroline Himbert; Kenneth Boucher; David W Wetter; Rachel Hess; Jaewhan Kim; Kelly Lundberg; Jennifer A Ligibel; Christopher A Barnes; Bailee Rushton; Robin Marcus; Samuel R G Finlayson Journal: BMJ Open Date: 2018-12-16 Impact factor: 2.692